# Voyager Therapeutics (VYGR) — Overview

VYGR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vygr

## Price

Last close $2.06 on Oct 15, 2026. 52-week range $2.01 – $5.33.

## Company profile

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $34.5M |
| Revenue (quarter) | $3.2M |
| Revenue growth (year over year) | -39.13% |
| Gross profit (trailing twelve months) | $34.5M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$107.7M |
| Net income (quarter) | −$24.5M |
| Net income growth (year over year) | 26.69% |
| Net margin | -312.63% |
| Return on equity | -54.09% |
| EPS (trailing twelve months) | −$1.81 |
| Book value per share | $2.52 |
| P/E (trailing twelve months) | — |
| Price to book | 0.8 |
| Debt to assets | 21.93% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Voyager Therapeutics (VYGR) profitable?

No. Voyager Therapeutics reported a net loss of $107.7M over the trailing twelve months.

### How much revenue does Voyager Therapeutics (VYGR) make?

Voyager Therapeutics generated $34.5M in revenue over the trailing twelve months, down 39.13% year over year.

### How do I buy stock in Voyager Therapeutics (VYGR)?

VYGR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).